Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 1
2004 1
2006 2
2008 2
2009 1
2010 3
2011 1
2012 3
2013 6
2014 8
2015 5
2016 8
2017 11
2018 5
2019 5
2020 17
2021 10
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

84 results
Results by year
Filters applied: . Clear all
Page 1
Glutamic acid promotes hair growth in mice.
Jara CP, de Andrade Berti B, Mendes NF, Engel DF, Zanesco AM, Pereira de Souza GF, de Medeiros Bezerra R, de Toledo Bagatin J, Maria-Engler SS, Morari J, Velander WH, Velloso LA, Araújo EP. Jara CP, et al. Among authors: maria engler ss. Sci Rep. 2021 Jul 29;11(1):15453. doi: 10.1038/s41598-021-94816-y. Sci Rep. 2021. PMID: 34326383 Free PMC article.
Redox-Related Proteins in Melanoma Progression.
Carvalho LAC, Queijo RG, Baccaro ALB, Siena ÁDD, Silva WA Jr, Rodrigues T, Maria-Engler SS. Carvalho LAC, et al. Among authors: maria engler ss. Antioxidants (Basel). 2022 Feb 22;11(3):438. doi: 10.3390/antiox11030438. Antioxidants (Basel). 2022. PMID: 35326089 Free PMC article.
Survivin modulation in the antimelanoma activity of prodiginines.
Branco PC, Pontes CA, Rezende-Teixeira P, Amengual-Rigo P, Alves-Fernandes DK, Maria-Engler SS, da Silva AB, Pessoa ODL, Jimenez PC, Mollasalehi N, Chapman E, Guallar V, Machado-Neto JA, Costa-Lotufo LV. Branco PC, et al. Among authors: maria engler ss. Eur J Pharmacol. 2020 Dec 5;888:173465. doi: 10.1016/j.ejphar.2020.173465. Epub 2020 Aug 16. Eur J Pharmacol. 2020. PMID: 32814079 Free article.
Indoleamine 2,3-dioxygenase in melanoma progression and BRAF inhibitor resistance.
Sandri S, Watanabe LRM, Oliveira EA, Faião-Flores F, Migliorini S, Tiago M, Felipe-Silva A, Vazquez VL, da Costa Souza P, Consolaro MEL, Campa A, Maria-Engler SS. Sandri S, et al. Among authors: maria engler ss. Pharmacol Res. 2020 Sep;159:104998. doi: 10.1016/j.phrs.2020.104998. Epub 2020 Jun 11. Pharmacol Res. 2020. PMID: 32535222 Free article.
TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors.
Oliveira ÉA, Chauhan J, Silva JRD, Carvalho LADC, Dias D, Carvalho DG, Watanabe LRM, Rebecca VW, Mills G, Lu Y, da Silva ASF, Consolaro MEL, Herlyn M, Possik PA, Goding CR, Maria-Engler SS. Oliveira ÉA, et al. Among authors: maria engler ss. Pharmacol Res. 2021 Nov;173:105911. doi: 10.1016/j.phrs.2021.105911. Epub 2021 Sep 22. Pharmacol Res. 2021. PMID: 34560251 Free PMC article.
Human leukocyte antigen (HLA)-G and cervical cancer immunoediting: a candidate molecule for therapeutic intervention and prognostic biomarker?
Gimenes F, Teixeira JJ, de Abreu AL, Souza RP, Pereira MW, da Silva VR, Bôer CG, Maria-Engler SS, Bonini MG, Borelli SD, Consolaro ME. Gimenes F, et al. Among authors: maria engler ss. Biochim Biophys Acta. 2014 Dec;1846(2):576-89. doi: 10.1016/j.bbcan.2014.10.004. Epub 2014 Oct 23. Biochim Biophys Acta. 2014. PMID: 25453366 Review.
Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma.
Smalley I, Kim E, Li J, Spence P, Wyatt CJ, Eroglu Z, Sondak VK, Messina JL, Babacan NA, Maria-Engler SS, De Armas L, Williams SL, Gatenby RA, Chen YA, Anderson ARA, Smalley KSM. Smalley I, et al. Among authors: maria engler ss. EBioMedicine. 2019 Oct;48:178-190. doi: 10.1016/j.ebiom.2019.09.023. Epub 2019 Oct 5. EBioMedicine. 2019. PMID: 31594749 Free PMC article.
84 results